- Home
- TLSI vs BEEP Comparison
TLSI vs BEEP Comparison
Compare TLSI & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- BEEP
- Stock Information
- Founded
- TLSI 2010
- BEEP 2015
- Country
- TLSI United States
- BEEP United States
- Employees
- TLSI N/A
- BEEP N/A
- Industry
- TLSI Medical Specialities
- BEEP Blank Checks
- Sector
- TLSI Health Care
- BEEP Finance
- Exchange
- TLSI Nasdaq
- BEEP Nasdaq
- Market Cap
- TLSI 160.4M
- BEEP 162.0M
- IPO Year
- TLSI N/A
- BEEP N/A
- Fundamental
- Price
- TLSI $5.21
- BEEP $4.05
- Analyst Decision
- TLSI Strong Buy
- BEEP Strong Buy
- Analyst Count
- TLSI 5
- BEEP 2
- Target Price
- TLSI $10.90
- BEEP $6.75
- AVG Volume (30 Days)
- TLSI 41.1K
- BEEP 22.3K
- Earning Date
- TLSI 05-15-2025
- BEEP 05-12-2025
- Dividend Yield
- TLSI N/A
- BEEP N/A
- EPS Growth
- TLSI N/A
- BEEP N/A
- EPS
- TLSI N/A
- BEEP N/A
- Revenue
- TLSI $32,141,000.00
- BEEP $36,416,000.00
- Revenue This Year
- TLSI $55.13
- BEEP $5.22
- Revenue Next Year
- TLSI $50.71
- BEEP $5.13
- P/E Ratio
- TLSI N/A
- BEEP N/A
- Revenue Growth
- TLSI 46.20
- BEEP 13.81
- 52 Week Low
- TLSI $3.50
- BEEP $2.48
- 52 Week High
- TLSI $7.55
- BEEP $4.86
- Technical
- Relative Strength Index (RSI)
- TLSI 46.54
- BEEP 53.04
- Support Level
- TLSI $4.95
- BEEP $3.90
- Resistance Level
- TLSI $5.68
- BEEP $4.15
- Average True Range (ATR)
- TLSI 0.40
- BEEP 0.29
- MACD
- TLSI 0.01
- BEEP 0.02
- Stochastic Oscillator
- TLSI 39.74
- BEEP 79.69
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.